Discovery of non-retinoid compounds that suppress the pathogenic effects of misfolded rhodopsin in a mouse model of retinitis pigmentosa
PLOS Biology · 14.01.2025 · 23 (1) · e3002932
DOI: 10.1371/journal.pbio.3002932 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 14.01.2025. Verfasst von Joseph T Ortega und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Cleveland Center for Membrane and Structural Biology, School of Medicine, Case Western Reserve University, Cleveland, …. Hauptthemen laut MEDLINE: Retinitis Pigmentosa, Rhodopsin. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIDA NIH HHS, NIH HHS.
Abstract (Originalsprache)
Pathogenic mutations that cause rhodopsin misfolding lead to a spectrum of currently untreatable blinding diseases collectively termed retinitis pigmentosa. Small molecules to correct rhodopsin misfolding are therefore urgently needed. In this study, we utilized virtual screening to search for drug-like molecules that bind to the orthosteric site of rod opsin and improve its folding and trafficking. We identified and validated the biological effects of 2 non-retinoid compounds with favorable pharmacological properties that cross the blood–retina barrier. These compounds reversibly bind to unliganded rod opsin, each with a K d comparable to 9- cis -retinal and improve opsin stability. By improving the internal protein structure network (PSN), these rod opsin ligands also enhanced the plasma membrane expression of total 36 of 123 tested clinical RP variants, including the most prevalent P23H variant. Importantly, these compounds protected retinas against light-induced degeneration in mice vulnerable to bright light injury and prolonged survival of photoreceptors in a retinitis pigmentosa mouse model for rod opsin misfolding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Cleveland Center for Membrane and Structural Biology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, United States of America.
- The James Tarpo Jr. and Margaret Tarpo Department of Chemistry, Purdue University, West Lafayette, Indiana, United States of America.
- Department of Chemistry, Indiana University, Bloomington, Indiana, United States of America.
- Department of Chemistry, Vanderbilt University, Nashville, Tennessee, United States of America.
- Structural Bioinformatics and High-Performance Computing Research Group (BIO-HPC), UCAM Universidad Católica de Murcia, Guadalupe, Spain.
- Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, United States of America.
ORCID-Profile: Beata Jastrzebska
Förderung
- NEI NIH HHS
- NIDA NIH HHS
- NIH HHS
- NCI NIH HHS
- NHLBI NIH HHS
- NIGMS NIH HHS
- National Institute of Health
- National Institutes of Health
Zitieren
APA
Ortega, J. T., Gallagher, J. M., McKee, A. G., Tang, Y., Carmena-Bargueňo, M., Azam, M., Pashandi, Z., Golczak, M., Meiler, J., Pérez-Sánchez, H., Schlebach, J. P., & Jastrzebska, B. (2025). Discovery of non-retinoid compounds that suppress the pathogenic effects of misfolded rhodopsin in a mouse model of retinitis pigmentosa. PLOS Biology, 23(1), e3002932. https://doi.org/10.1371/journal.pbio.3002932
Vancouver
Ortega JT, Gallagher JM, McKee AG, Tang Y, Carmena-Bargueňo M, Azam M, et al. Discovery of non-retinoid compounds that suppress the pathogenic effects of misfolded rhodopsin in a mouse model of retinitis pigmentosa. PLOS Biology. 2025;23(1):e3002932. doi:10.1371/journal.pbio.3002932
BibTeX
@article{Ortega2025,
author = {Ortega, Joseph T and Gallagher, Jacklyn M and McKee, Andrew G and Tang, Yidan and Carmena-Bargueňo, Miguel and Azam, Maria and Pashandi, Zaiddodine and Golczak, Marcin and Meiler, Jens and Pérez-Sánchez, Horacio and Schlebach, Jonathan P and Jastrzebska, Beata},
title = {Discovery of non-retinoid compounds that suppress the pathogenic effects of misfolded rhodopsin in a mouse model of retinitis pigmentosa},
journal = {PLOS Biology},
year = {2025},
volume = {23},
number = {1},
pages = {e3002932},
doi = {10.1371/journal.pbio.3002932}
}
EUVIMED